Literature DB >> 16403444

mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level.

Michael Mockey1, Cristine Gonçalves, Franck P Dupuy, François M Lemoine, Chantal Pichon, Patrick Midoux.   

Abstract

The occurrence of translation mechanism in the cytosol offers advantages to mRNA transfer over DNA-based transfection in non-dividing cells. Here, we sought to optimize mRNA constructs allowing a high level of protein upon lipofection. We found that luciferase into mouse dendritic cells (JAWSII cells) was approximately 20-fold higher when the luciferase mRNA was capped with 3'-O-methyl-m7(5')Gppp5'G (anti-reverse cap analogue; ARCA) than with m7(5')Gppp5'G (CAP). Adding a Poly(A) tail of 100 instead of 64 adenosines in cis increased by approximately 35-fold more the protein level. Finally, ARCA-Luc-mRNA-A100 construct was 700-fold better efficient than the CAP-Luc-mRNA-A64 one. Moreover, co-transfection with free Poly(A) chains in trans enhanced by 100% the luciferase level. The efficiency of ARCA-mRNA-A100 construct was validated in immature and mature human CD34-derived dendritic cells. Such mRNA construct was also successful to obtain high level of MART-1 tumor antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403444     DOI: 10.1016/j.bbrc.2005.12.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

Review 1.  Developing mRNA-vaccine technologies.

Authors:  Thomas Schlake; Andreas Thess; Mariola Fotin-Mleczek; Karl-Josef Kallen
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

Review 2.  An RNA toolbox for cancer immunotherapy.

Authors:  Fernando Pastor; Pedro Berraondo; Iñaki Etxeberria; Josh Frederick; Ugur Sahin; Eli Gilboa; Ignacio Melero
Journal:  Nat Rev Drug Discov       Date:  2018-09-07       Impact factor: 84.694

Review 3.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

4.  A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.

Authors:  Yoonsu Choi; Carrie Yuen; Sourindra N Maiti; Simon Olivares; Hillary Gibbons; Helen Huls; Robert Raphael; Thomas C Killian; Daniel J Stark; Dean A Lee; Hiroki Torikai; Daniel Monticello; Susan S Kelly; Partow Kebriaei; Richard E Champlin; Sibani L Biswal; Laurence J N Cooper
Journal:  Biomed Microdevices       Date:  2010-10       Impact factor: 2.838

Review 5.  Messenger RNA (mRNA) nanoparticle tumour vaccination.

Authors:  Kyle K L Phua; Smita K Nair; Kam W Leong
Journal:  Nanoscale       Date:  2014-07-21       Impact factor: 7.790

Review 6.  Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

Authors:  Zeljka Trepotec; Eva Lichtenegger; Christian Plank; Manish K Aneja; Carsten Rudolph
Journal:  Mol Ther       Date:  2018-12-22       Impact factor: 11.454

Review 7.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

8.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

9.  Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells.

Authors:  Ewa Grudzien-Nogalska; Jacek Jemielity; Joanna Kowalska; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2007-08-24       Impact factor: 4.942

10.  Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS.

Authors:  Joanna Kowalska; Magdalena Lewdorowicz; Joanna Zuberek; Ewa Grudzien-Nogalska; Elzbieta Bojarska; Janusz Stepinski; Robert E Rhoads; Edward Darzynkiewicz; Richard E Davis; Jacek Jemielity
Journal:  RNA       Date:  2008-04-22       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.